Inhibrx (INBX) Stock Chart & Stock Price History $12.16 +0.29 (+2.44%) Closing price 04/23/2025 04:00 PM EasternExtended Trading$11.58 -0.57 (-4.73%) As of 09:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Inhibrx Stock Price Performance 5 Day Performance+6.02%1 Month Performance-17.39%3 Month Performance-7.53%6 Month Performance-20.88%Year-To-Date Performance-21.04%1 Year Performance-64.63% Receive INBX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. Email Address INBX Stock Chart for Thursday, April, 24, 2025 INBX Chart by TradingView Inhibrx Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2025$11.87$12.16+2.44%$12.69$12.0051,435 shs$176.03 million04/22/2025$11.38$11.87+4.31%$11.95$11.4052,139 shs$171.83 million04/21/2025$11.47$11.38-0.78%$11.72$11.22149,984 shs$164.74 million04/18/2025$11.47$11.47$11.79$11.2584,648 shs$166.04 million04/17/2025$11.47$11.47$11.79$11.2584,648 shs$166.04 million04/16/2025$11.79$11.47-2.71%$12.04$11.3963,201 shs$166.04 million04/15/2025$11.88$11.79-0.76%$12.06$11.5772,015 shs$170.67 million04/14/2025$11.61$11.88+2.33%$12.03$11.50101,484 shs$171.98 million04/11/2025$11.32$11.61+2.56%$11.77$10.81103,135 shs$168.07 million04/10/2025$12.35$11.32-8.34%$12.20$11.10139,986 shs$163.87 million Get the Latest News and Ratings for INBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. 04/09/2025$11.69$12.35+5.65%$12.61$10.87179,471 shs$178.78 million04/09/2025$11.69$12.35+5.65%$12.61$10.87179,471 shs$178.78 million04/08/2025$12.00$11.69-2.58%$12.80$11.46306,972 shs$169.22 million04/08/2025$12.00$11.69-2.58%$12.80$11.46306,972 shs$169.22 million04/07/2025$13.34$12.00-10.04%$14.00$11.89248,217 shs$173.71 million04/04/2025$13.33$13.34+0.08%$14.08$12.46270,761 shs$193.11 million04/03/2025$14.10$13.33-5.46%$14.10$13.32220,446 shs$192.97 million04/02/2025$14.05$14.10+0.36%$14.16$13.53205,018 shs$204.11 million04/01/2025$13.99$14.05+0.43%$14.14$13.53201,067 shs$203.39 million03/31/2025$14.12$13.99-0.92%$14.40$13.51133,002 shs$202.52 million03/28/2025$14.32$14.12-1.40%$14.64$13.97122,051 shs$204.40 million03/27/2025$14.24$14.32+0.56%$14.47$14.0546,745 shs$207.30 million03/26/2025$14.22$14.24+0.14%$14.44$14.0576,794 shs$206.14 million03/25/2025$14.72$14.22-3.40%$15.19$14.1183,237 shs$205.85 million03/24/2025$14.35$14.72+2.58%$14.91$13.85109,809 shs$213.09 million Related Companies Dianthus Therapeutics Stock Price Chart AnaptysBio Stock Price Chart Xeris Biopharma Stock Price Chart Arbutus Biopharma Stock Price Chart ChromaDex Stock Price Chart Arvinas Stock Price Chart KalVista Pharmaceuticals Stock Price Chart Trevi Therapeutics Stock Price Chart Keros Therapeutics Stock Price Chart VectivBio Stock Price Chart Receive INBX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INBX) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredThis Crypto Is Set to Explode in JanuaryThe crypto summit Wall Street wants to stop Learn how to structure your portfolio like the top hedge funds...Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibrx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibrx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INBX Stock Free INBX Stock Alerts